Tackling Obesity: Multidisciplinary Approaches for Comprehensive Care

---

LIVEFACE-TO-FACEDHPAMA

Saturday, January 25, 2025, 10:30 AM - 7:30 PM, Hilton Doha, Doha, Qatar

This 1-day symposium aims to provide the healthcare professionals with up-to-date weight management strategies from lifestyle interventions to advanced therapies. This activity will include lectures as well as interactive sessions e.g. Q&A. It will be delivered in collaboration with speakers from local, regional and international institutions.

1. Recognize the impact of obesity and weight loss on health
2. Describe evidence-based strategies to manage obesity from lifestyle interventions to advanced therapies.
3. Formulate an individualized patient-centered plan to manage patients before, during and after weight loss.

• Early bird rate (valid until January 11, 2025): QAR 190/USD 52
• Regular rate (from January 12, 2025): QAR 250/USD 69

 

Changes or Cancellations

1- Name changes or substitutions are not permitted.
2- All cancellation and refund requests must be made in writing and submitted via email to [email protected].
3- For a full refund of the registration fee, the cancellation request must be received at least 7 days prior to the session. No refund will be offered for cancellation request thereafter.
4- We will attempt to process the refund within 30 days of receiving any cancellation request.
5- Weill Cornell Medicine-Qatar reserves the right to cancel the course. In the event of a cancellation, fee deposit will be returned, but we will not be responsible for any other expenses including restricted or non-refundable airfare or hotel deposits.

REGISTRATION WARNING

Registration for courses managed by Weill Cornell Medicine-Qatar (WCM-Q) can only be completed through WCM-Q's official registration portal. Attendee registrations made through any other sites cannot be honored. WCM-Q is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com.

Please report any unauthorized websites or solicitations for registrations to  [email protected].

DHP 

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Ministry of Public Health's Department of Healthcare Professions.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 6.5 hours.

ACCME

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this Live Activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to the Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Scientific Planning Committee: Tariq Chukir, MD, Deema Al-Sheikhly, MEHP, Phyllis Sui Muffuh Navti, DHSci, Rewa Refai, LD, Rowena Verzosa, MSN 
Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.
Will not be discussing unlabeled/unapproved use of drugs or products.

Course Director/ICR: Tariq Chukir, MD
Has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.
Will not be discussing unlabeled/unapproved use of drugs or products.

Course Faculty: Tariq Chukir, MD, Hiba Bawadi, PhD, Noor Nabeel Suleiman, MD, Bassem Safadi, MD, Shahrad Taheri, MD, Roberto Simons-Linares, MD, Turki Al-Ahbabi, MD, Michael Weintraub, MD, Abdul Badi Abou Samra, MD, Rewa Refai, LD
Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.
Will not be discussing any unlabeled/unapproved use of drugs or products. 

Saif Azzawi, MD, has disclosed the following financial relationship: 
Executive - Project Rozana, UK
All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated.
Will not be discussing unlabeled/unapproved use of drugs or products.

Beverly Tchang, MD, has disclosed the following financial relationship: 
Advisor - Novo Nordisk
All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated.
Will not be discussing unlabeled/unapproved use of drugs or products.

Administrative Contact: Safia Rabia, Irina Gerasimova

 Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.

 Will not be discussing unlabeled/unapproved use of drugs or products.

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.

Mitigation of Relevant Financial Relationships

 Weill Cornell Medicine-Qatar adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Saturday, January 25, 2025